PROVIDER PROFILE · NPI 1013171313

Sarat ChandarlapatyM.D., PH.D.

PRESCRIBING · PART D · 2024
Total Rx claims
51
Beneficiaries
—
Total drug cost
$454K
Distinct drugs
4
Brand share
47.1%
Top prescribed drugs
Exemestane16 claims
Palbociclib13 claims
Letrozole11 claims
Tucatinib11 claims
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital